Andres Ruiz Briseno
Chief Accounting OfficerMr. Andres Ruiz Briseno, C. P.A. served as Advisory Board Member at Rosalind Scientific LLC until 2023. He serves as Chief Accounting Officer at IDEAYA Biosciences, Inc. from March 2025 and had been Principal Accounting Officer, Senior VP and Head of Finance since July 01, 2023 until 2025 and serves as its Head of Investor Relations since November 2021 and served as its Vice President and Head of Business Operations since November 2021 until July 01, 2023 and served as its Vice President of Finance since July 2019 and served as its Controller since August 2016 until July 2019. From July 2021 to October 2021, Mr. Briseno was Senior Vice President, Finance & Principal Accounting Officer at Neumora Therapeutics. Previously, he held roles at Company from August 2016 to July 2021, including most recently as Vice President, Finance. Mr. Briseno served as Senior Director of Finance at IDEAYA Biosciences, Inc. until July 2019. Prior to joining this, from September 2013 to August 2016, Mr. Briseno held several roles at Pharmacyclics, Inc. a biopharmaceutical company (acquired by AbbVie Inc. in May 2015), including most recently as Associate Director of Financial Planning and Analysis. Previously, from September 2009 to September 2013, Mr. Briseno held roles at Theravance, Inc. and PricewaterhouseCoopers LLP. He obtained his B. S. in Business Administration with a concentration in Corporate Financial Management from San Jose State University. He is a Certified Public Accountant, licensed in the state of California.
公司职务
- 公司名称IDEAYA Biosciences, Inc.股票代码IDYA职务Chief Accounting Officer共事同僚
- YSYujiro S. HataFounder, President, CEO & Chairman
- JBJoshua BleharskiChief Financial Officer
- DBDouglas B. SnyderChief Legal Officer
- MAMichael A. WhitePresident of Research & Development
- JLJeffrey L. SteinIndependent Director
- SWScott William MorrisonIndependent Director
- FPFrank P. McCormickChair of Scientific Advisory Board
- TJTerry J. RosenLead Independent Director
